Rebecca Mack

Pharmacokinetic Interactions of Maraviroc with Darunavir-Ritonavir, Etravirine, and Etravirine-Darunavir-Ritonavir in Healthy Volunteers: Results of Two Drug Interaction Trials

M. Schöller-Gyüre, T. Kakuda, R. Hoetelmans, 2011, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents

Christoph Königs, Claudio Viscoli, Susanna Esposito, 2012, AIDS.

Pharmacokinetics of Elvitegravir and Etravirine following Coadministration of Ritonavir-Boosted Elvitegravir and Etravirine

B. Kearney, T. Kakuda, S. Ramanathan, 2008, Antiviral therapy.

Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients

C. Cohen, M. de Béthune, D. Berger, 2009, AIDS.

Effect of Ritonavir-Boosted Tipranavir or Darunavir on the Steady-State Pharmacokinetics of Elvitegravir

A. Mathias, B. Kearney, J. Enejosa, 2008, Journal of acquired immune deficiency syndromes.